VEITINGER KLAUS R DR 4
4 · scPharmaceuticals Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
VEITINGER KLAUS R DR
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-08+16,300→ 16,300 totalExercise: $5.70Exp: 2031-06-08→ Common Stock (16,300 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders.